Related Experiment Video
Updated: Jan 17, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Evaluation of Pediatric Cardiomyopathy Patients in Pediatric Intensive Care Unit
Şeyda Kesen1, Merve Havan2, Mehmet Ramoğlu3
1Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
Insights
Pediatric cardiomyopathies (CMP) often lead to severe heart failure, requiring intensive care, mechanical ventilation, and advanced circulatory support like ECMO and LVAD. Outcomes remain poor, with over half of patients in this study dying despite aggressive treatments.
Area of Science:
- Pediatric Cardiology
- Intensive Care Medicine
- Cardiovascular Research
Background:
- Cardiomyopathies (CMP) are a significant cause of end-stage heart failure in children.
- Understanding the clinical course and treatment needs of pediatric CMP patients in the intensive care setting is crucial.
Purpose of the Study:
- To evaluate the clinical features, treatments, and outcomes of pediatric patients diagnosed with CMP.
- To analyze the utilization of intensive care resources and advanced therapies in managing severe pediatric heart failure due to CMP.
Main Methods:
- Retrospective analysis of 76 pediatric patients diagnosed with CMP admitted to the pediatric intensive care unit (PICU) between 2008 and 2019.
- Data collected included demographics, CMP type, diagnostic findings, medical and respiratory/circulatory support, cardiac transplantation, and patient outcomes.
Main Results:
- Dilated cardiomyopathy was the most common type (68.4%).
- The majority of patients required diuretics (90.8%), inotropes (93.4%), and invasive mechanical ventilation (75%).
- Advanced support included extracorporeal membrane oxygenation (ECMO) in 43.4%, left ventricular assist device (LVAD) in 15.8%, and biventricular assist device (BiVAD) in 2.6%; 13.2% underwent heart transplantation, with a mortality rate of 52.6%.
Conclusions:
- Pediatric CMP patients with severe heart failure necessitate intensive care with advanced interventions like mechanical ventilation, ECMO, LVAD, BiVAD, and heart transplantation.
- Despite aggressive management, mortality remains high, highlighting the critical need for specialized pediatric intensive care and ongoing research into novel therapies.
Abstract:
Objective: Cardiomyopathies (CMP) are an important cause of end-stage heart failure in childhood. The study aims to evaluate the clinical features, treatments, and outcomes of the patients diagnosed with CMP followed in the pediatric intensive care unit (PICU). Materials and Methods: This retrospective study was conducted using the data of the patients followed in the PICU between January 1, 2008, and December 31, 2019. Demographic information of the patients, CMP types, informations of echocardiography and angiography, findings upon admission to the PICU, medical treatments applied, respiratory and circulatory support, cardiac transplantation status, and results were examined. Results: A total of 76 patients hospitalized with the diagnosis of CMP were included in the study. Among them, 39 (51%) patients were female. The majority (68.4%) were diagnosed with dilated CMP. The remaining patients were diagnosed with noncompaction left ventricular (LV) dilated CMP (14.5%), restrictive CMP (10.5%), hypertrophic CMP (5.3%), and noncompaction LV restrictive CMP (1.3%). Diuretics, inotropes, and invasive mechanical ventilation were used in 90.8%, 93.4%, and 75% of patients, respectively. While 43.4% (n = 33) of the patients needed extracorporeal membrane oxygenation (ECMO) support during their PICU hospitalization, 15.8% (n = 12) received LV assist device (LVAD) and 2.6% (n = 2) biventricular assist device (BiVAD) support. Heart transplantation was performed in 10 patients (13.2%). Finally, 40 (52.6%) of the patients died. Conclusion: Pediatric patients with CMP with severe heart failure require inotropes, mechanical ventilation, ECMO, LVAD, BiVAD, and heart transplantation, which are crucial for lifesaving measures, along with intensive care follow-up.
More Related Videos
09:31Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation